These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 11733963
1. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Scarabelli C, Gallo A, Carbone A. Gynecol Oncol; 2001 Dec; 83(3):504-12. PubMed ID: 11733963 [Abstract] [Full Text] [Related]
2. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Zang RY, Zhang ZY, Li ZT, Cai SM, Tang MQ, Chen J, Liu Q. Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649 [Abstract] [Full Text] [Related]
4. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Chi DS, McCaughty K, Diaz JP, Huh J, Schwabenbauer S, Hummer AJ, Venkatraman ES, Aghajanian C, Sonoda Y, Abu-Rustum NR, Barakat RR. Cancer; 2006 May 01; 106(9):1933-9. PubMed ID: 16572412 [Abstract] [Full Text] [Related]
5. [Secondary debulking surgery and intraperitoneal chemotherapy in advanced or recurrent epithelial ovarian cancer]. Plaisant N, Quenet F, Fabbro M, Gourgou S, Gutowski M, Saint-Aubert B, Rouanet P. Gynecol Obstet Fertil; 2004 May 01; 32(5):391-7. PubMed ID: 15177208 [Abstract] [Full Text] [Related]
6. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy. Matsumoto A, Higuchi T, Yura S, Mandai M, Kariya M, Takakura K, Fujii S. J Obstet Gynaecol Res; 2006 Dec 01; 32(6):580-7. PubMed ID: 17100820 [Abstract] [Full Text] [Related]
7. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Salani R, Santillan A, Zahurak ML, Giuntoli RL, Gardner GJ, Armstrong DK, Bristow RE. Cancer; 2007 Feb 15; 109(4):685-91. PubMed ID: 17219441 [Abstract] [Full Text] [Related]
8. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC). Cheng X, Jiang R, Li ZT, Tang J, Cai SM, Zhang ZY, Tian WJ, Zang RY. Eur J Surg Oncol; 2009 Oct 15; 35(10):1105-8. PubMed ID: 19443175 [Abstract] [Full Text] [Related]
9. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Munkarah A, Levenback C, Wolf JK, Bodurka-Bevers D, Tortolero-Luna G, Morris RT, Gershenson DM. Gynecol Oncol; 2001 May 15; 81(2):237-41. PubMed ID: 11330956 [Abstract] [Full Text] [Related]
10. [Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer]. Meier W, Römisch M, Hepp H. Geburtshilfe Frauenheilkd; 1993 Dec 15; 53(12):860-5. PubMed ID: 8119569 [Abstract] [Full Text] [Related]
11. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer. Munkarah AR, Coleman RL. Gynecol Oncol; 2004 Nov 15; 95(2):273-80. PubMed ID: 15491746 [Abstract] [Full Text] [Related]
12. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience. Pavlov MJ, Kovacevic PA, Ceranic MS, Stamenkovic AB, Ivanovic AM, Kecmanovic DM. Eur J Surg Oncol; 2009 Nov 15; 35(11):1186-91. PubMed ID: 19356887 [Abstract] [Full Text] [Related]
13. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Vaccarello L, Rubin SC, Vlamis V, Wong G, Jones WB, Lewis JL, Hoskins WJ. Gynecol Oncol; 1995 Apr 15; 57(1):61-5. PubMed ID: 7705701 [Abstract] [Full Text] [Related]
14. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Santillan A, Karam AK, Li AJ, Giuntoli R, Gardner GJ, Cass I, Karlan BY, Bristow RE. Gynecol Oncol; 2007 Mar 15; 104(3):686-90. PubMed ID: 17141302 [Abstract] [Full Text] [Related]
15. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer. Fotiou S, Aliki T, Petros Z, Ioanna S, Konstantinos V, Vasiliki M, George C. Gynecol Oncol; 2009 Aug 15; 114(2):178-82. PubMed ID: 19450872 [Abstract] [Full Text] [Related]
16. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Gadducci A, Iacconi P, Fanucchi A, Cosio S, Teti G, Genazzani AR. Anticancer Res; 2000 Aug 15; 20(3B):1959-64. PubMed ID: 10928134 [Abstract] [Full Text] [Related]
17. [Analysis of treatment and prognosis of recurrent epithelial ovarian carcinoma]. Yuan GW, Wu LY, Yao HW, Hou JL, Li XG, Liu LY. Zhonghua Zhong Liu Za Zhi; 2009 Sep 15; 31(9):710-3. PubMed ID: 20021871 [Abstract] [Full Text] [Related]
18. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer. Karam AK, Chiang JW, Fung E, Nossov V, Karlan BY. Gynecol Oncol; 2009 Aug 15; 114(2):246-52. PubMed ID: 19500821 [Abstract] [Full Text] [Related]
19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
20. The role of secondary cytoreductive surgery in epithelial ovarian malignancies. Williams L. Oncology (Williston Park); 1992 Aug 15; 6(8):25-32; discussion 37-9. PubMed ID: 1386995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]